Comparison of minimal residual disease detection in multiple myeloma between SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry methods

被引：0
|
作者：
Takamatsu, Hiroyuki [1 ]
Yoroidaka, Takeshi [1 ]
Fujisawa, Momoko [1 ]
Kobori, Kazuya [2 ]
Hanawa, Masako [2 ]
Yamashita, Takeshi [3 ]
Murata, Ryoichi [3 ]
Ueda, Mikio [3 ]
Nakao, Shinji [1 ]
Matsue, Kosei [4 ]
机构：
[1] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[2] SRL Inc, Tokyo, Japan
[3] Keiju Kanazawa Hosp, Kanazawa, Ishikawa, Japan
[4] Kameda Med Ctr, Kamogawa, Japan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Minimal residual disease; multiparameter flow cytometry;
D O I：
10.1016/j.clml.2019.09.307
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-222
引用
收藏
页码：E183 / E184
页数：2
相关论文
共 50 条
  • [41] Assessment of response to therapy in multiple myeloma by multiparameter flow cytometry. Usefulness of an eight-color single tube with monoclonal antibodies in dried formulation
    Carulli, G.
    Tarasco, A.
    Sammuri, P.
    Ottaviano, V
    Domenichini, C.
    Ciancia, E. M.
    Petrini, M.
    CLINICA TERAPEUTICA, 2019, 170 (05): : E352 - E356
  • [42] Minimal Residual Disease Monitoring By 8-Color Flow Cytometry in Mantle Cell Lymphoma Is Complementary to Q-PCR Monitoring and Will Facilitate Pre-Emptive Treatment: An EU-MCL and Lysa Study
    Cheminant, Morgane
    Schmit, Stephanie
    Touzart, Aurore
    Derrieux, Coralie
    Delfau-Larue, Marie Helene
    Thieblemont, Catherine
    Ribrag, Vincent
    Ysebaert, Loic
    Jardin, Fabrice
    Cheze, Stephane
    Lefrere, Francois
    Delarue, Richard
    Pott, Christiane
    Hotter, Eva
    Dreyling, Martin
    Asnafi, Vahid
    Hermine, Olivier
    Macintyre, Elizabeth
    BLOOD, 2014, 124 (21)
  • [43] Minimal Residual Disease (MRD) By 8-Color Flow Cytometry (Flow-MRD) and IGH Clonospecific Quantitative PCR (ASO RQPCR) Reached Similar Performances for Evaluation of CLL Treatment in a Phase II Clinical Trial: Cross Validation of the Methods
    Letestu, Remi
    Cartron, Guillaume
    Lepretre, Stephane
    Le Garff-Tavernier, Magali
    Solly, Francoise
    Campos, Lydia
    Ticchioni, Michel
    Quiney, Claire
    Dahmani, Abdelmalek
    Boubaya, Marouane
    Levy, Vincent
    Cymbalista, Florence
    Delfau-Larue, Marie-Helene
    BLOOD, 2014, 124 (21)
  • [44] Comparison of Minimal Residual Disease Detection between the Manual and Automated Gating Strategies of Euroflow Next-Generation Flow in Patients with Multiple Myeloma
    Takamatsu, Hiroyuki
    Yoroidaka, Takeshi
    Yamashita, Takeshi
    Murata, Ryoichi
    Ueda, Mikio
    Nakao, Shinji
    Matsue, Kosei
    BLOOD, 2019, 134
  • [45] COMPARISON BETWEEN THE INTERNATIONAL STANDARDISED APPROACH AND A SINGLE TUBE TEN COLOUR FLOW CYTOMETRIC ASSAY FOR DETECTION OF MINIMAL RESIDUAL DISEASE IN CLL
    Sartor, M.
    Gottlieb, D.
    HAEMATOLOGICA, 2012, 97 : 62 - 62
  • [46] Comparison Between the International Standardised Approach and a Single Tube Ten Colour Flow Cytometric Assay for Detection of Minimal Residual Disease in CLL
    Sartor, Mary M.
    Bradstock, Kenneth Francis
    Gottlieb, David
    BLOOD, 2011, 118 (21) : 634 - 634
  • [47] Simultaneous detection of decidual Th1/Th2 and NK1/NK2 immunophenotyping in unknown recurrent miscarriage using 8-color flow cytometry with FSC/Vt extended strategy
    Dong, Peng
    Wen, Xi
    Liu, Jia
    Yan, Cui-Yan
    Yuan, Jing
    Luo, Lan-Rong
    Hu, Qiao-Fei
    Li, Jian
    BIOSCIENCE REPORTS, 2017, 37
  • [48] Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL) via an 8 color flow cytometry panel comprising the signature gene ROR1
    Patz, Michaela
    Pentok, Barbara
    Cremer, Kathrin
    Linnartz, Stefanie
    Lilienweiss, Esther
    Kleinert, Fanni
    Hallek, Michael
    Kreuzer, Karl-Anton
    LEUKEMIA & LYMPHOMA, 2017, 58 : 93 - 94
  • [49] Minimal residual disease (MRD) analysis in the bone marrow (BM) of multiple myeloma (MM) patients (pts) using a 6-color multiparameter flow cytometry (MFC) approach detecting exclusively surface antigens
    Dold, S. M.
    Bartsch, I.
    Wider, D.
    Mueller, S. J.
    Waldschmidt, J. M.
    Koehler, M.
    Pantic, M.
    Rawluk, J.
    Duyster, J.
    Zlei, M.
    Azab, A. K.
    Brueggemann, M.
    Binder, M.
    Zeiser, R.
    Waesch, R.
    Engelhardt, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 86 - 86
  • [50] Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (10)
12345